Lidocaine Hcl And Epinephrine Injection, Solution
Product Images NDC 51662-1504

14 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl And Epinephrine (NDC 51662-1504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Description (Description)

Description (Description)
A table presenting the concentrations of Lidocaine HCl, Epinephrine, and Sodium Chloride in various formulations of Lidocaine HCl and Epinephrine injection solutions. It lists Lidocaine HCl percentages from 0.5% to 2%, Epinephrine ratios of 1:200,000 and 1:100,000, corresponding Lidocaine HCl (anhydrous) mg/mL, Epinephrine mcg/mL, and Sodium Chloride mg/mL values for each formulation.*
FDA Label Image

Structure 1 (Structure 1)

Structure 1 (Structure 1)
Chemical structure diagram of lidocaine hydrochloride monohydrate, one active ingredient in the Lidocaine HCl and Epinephrine injection solution by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Structure 2 (Structure 2)

Structure 2 (Structure 2)
Chemical structure diagram showing a molecular formula with a benzene ring, hydroxyl groups, and an aminoethyl side chain, representing the chemical structure of an active ingredient associated with lidocaine HCl and epinephrine injection solution.*
FDA Label Image

Precautions (Precautions 1)

Precautions (Precautions 1)
A data table categorizing various drug classes and providing examples of each. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with example drugs listed under each category.*
FDA Label Image

Dosage (Dosage)

Dosage (Dosage)
Table showing recommended dosages of Lidocaine Hydrochloride Injection, USP (without Epinephrine) for various procedures. It includes concentration percentages, volume in milliliters, and total dose in milligrams for infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks with specified procedural examples.*
FDA Label Image

How Supplied (How Supplied 1)

How Supplied (How Supplied 1)
A data table listing unit of sale, concentration, and package details for Lidocaine HCl and Epinephrine injection solutions. It shows various single-dose, epidural test dose, and multiple-dose options with different vial sizes and concentrations ranging from Lidocaine HCl 0.5% to 2% combined with Epinephrine at ratios from 1:100,000 to 1:200,000.*
FDA Label Image
FDA Label Image

51662-1504 50 mL Vial Label (51662 1504 1 Vial Label)

51662-1504 50 mL Vial Label (51662 1504 1 Vial Label)
Label for LIDOCAINE HCl 2% and EPINEPHRINE 1:100,000 Injection, USP, 50 mL multiple-dose vial. The label states use for infiltration and nerve block, and warnings against epidural or caudal use. Distributed by Hospira Inc. The label details active ingredient strengths and stabilizers, with storage instructions and pH information included.*
FDA Label Image

51662-1504 50 mL Alternate Vial Label (51662 1504 1 Vial Label Alternate)

51662-1504 50 mL Alternate Vial Label (51662 1504 1 Vial Label Alternate)
Label of LIDOCAINE HCl 2% and EPINEPHRINE 1:100,000 Injection, USP, 50 mL multiple-dose vial. It is for infiltration and nerve block use, not for epidural or caudal use. The label includes dosing information and usage warnings. Distributed by Hospira Inc., Lake Forest, IL.*
FDA Label Image

Rfid Label (51662 1504 1 Rfid Label)

Rfid Label (51662 1504 1 Rfid Label)
A close-up image of a drug product label for LIDOCAINE HCl AND EPINEPHRINE injection solution by HF Acquisition Co LLC. The label shows a GS1 DataMatrix barcode and several identification codes, including the NDC 00351662150412, expiration date 230919, and a lot number HF1234TESTING. The label also advises to see the manufacturer's insert and lists distributor information for HF Acquisitions Co, LLC, located in Mukilteo, WA 98275.*
FDA Label Image

Case Labeling (51662 1504 3 00351662150436 Lidocaine Case Label)

Case Labeling (51662 1504 3 00351662150436 Lidocaine Case Label)
Label for Lidocaine HCl 2% and Epinephrine 1:100,000 injection, USP in a 50 mL vial, packaged in a box of 25. Displays NDC 51662-1504-3, lot number 12345, and expiration date 2025-01-01. Manufactured by HF Acquisition Co, LLC in Mukilteo, WA. Label includes storage and usage instructions, emphasizing protection from light, sterile use, and storage temperatures.*
FDA Label Image

Rfid Label (51662 1504 3 Rfid)

Rfid Label (51662 1504 3 Rfid)
A close-up image of a pharmaceutical label for Lidocaine HCl and Epinephrine injection, solution. The label displays various identifying codes including a barcode and text markings such as the product identifier (NDC), lot number, manufacturing, and distribution information by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label instructs to see the manufacturer's insert for additional information.*
FDA Label Image

Pouch Label (51662 1504 2 00351662150429 Lidocaine Pouch Label)

Pouch Label (51662 1504 2 00351662150429 Lidocaine Pouch Label)
Label for Lidocaine HCl 2% and Epinephrine 1:100,000 Injection, USP in a 50 mL vial by HF Acquisition Co LLC. The label includes the NDC 51662-1504-2, lot number 12345, and expiration date 2025-01-01. It specifies storage instructions, protection from light, and administration routes as infiltration and nerve block.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.